The House Ways and Means Committee advanced several bills yesterday to combat the opioid epidemic.
WASHINGTON, DC – The House Ways and Means Committee advanced several bills yesterday to combat the opioid epidemic. Unfortunately, the package included a weakened alternative to the Synthetics Trafficking and Overdose Prevention (STOP) Act that would continue allowing illicit opioids to flood into the United States through the international mail. Shatterproof Founder and CEO Gary Mendell issued the following statement in opposition to the bill.
“I am encouraged by the House Ways and Means Committee’s decision to take action to address the opioid crisis, but the proposed legislation to stop synthetic opioids from coming into our country is full of loopholes that render it completely ineffective. Rather than ensuring our government’s intelligence and law enforcement systems can properly screen packages shipped from foreign countries that may contain illicit substances like fentanyl, this alternative version of the STOP Act removed the critical tools and penalties needed for proper enforcement. As this proposal moves forward in the process, I urge the House and Senate to work together to pass H.R. 1057 instead, a bipartisan bill with more than 270 sponsors that would actually stop dangerous drugs from coming into our country and protect our friends and families.”
About Gary Mendell:
Gary Mendell is the Founder and CEO of Shatterproof. He founded Shatterproof to spare others the tragedy his family suffered with the loss of his son Brian to addiction in 2011. Mr. Mendell is an experienced businessman and CEO who founded HEI Hotels & Resorts and is the former president of Starwood Lodging Trust.
Shatterproof is a national nonprofit organization dedicated to reducing the devastation the disease of addiction causes families. Shatterproof works to end the stigma and foster a community of support, providing evidence-based resources to support prevention, treatment and recovery. Shatterproof advocates for changes in policy at the federal and state level and supports the development and implementation of evidence-based solutions for substance use disorders.